|Articles|November 18, 2003

Corneal collagen crosslinking safely halts keratoconus progression

Crosslinking of corneal collagen by topical treatment with riboflavinand ultraviolet light exposure shows promise as a safe and effective nonsurgicaltreatment for keratoconus, according to data presented by Theo Seiler, MD,PhD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME